IMU Biosciences
- Health & Biotech
- London, GB
- Private
- imubiosciences.com
Biotech applying high-resolution immune profiling to transplantation and immuno-oncology; raised over $53M in a Series A in June 2026.
$53MEquity raised in 2025–20262025 — · 2026 $53M · 1 equity round
$53MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed
Rounds over time log-scaled amounts
Funding history 1 round · 1 source
Earlier rounds not yet sourced. IMU Biosciences raised before 2 Jun 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.
- Series AAmount$53MGBP 40MPost-money—✓ Confirmed
- Earlier rounds not yet sourced
Investors 4
- IQ Capital1
- Molten Ventures1
- British Business Bank
- Meltwind
Highlighted investors led at least one equity round; the number is equity rounds taken part in.
Related companies shared investors
Gravis RoboticsRobotics · $223M in 2025–2026Shared: IQ CapitalMannaRobotics · $50M in 2025–2026Shared: Molten VenturesIsar AerospaceDefense · $312M in 2025–2026Shared: Molten VenturesPliantFintech · $120M in 2025–2026Shared: Molten VenturesTropicDeep Tech · $105M in 2025–2026Shared: IQ CapitalIsembardDeep Tech · $50M in 2025–2026Shared: IQ Capital
Also in the London hub see on the globe
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. IMU Biosciences and its logo are trademarks of their owners, used here for identification only.
